Further analysis with clinical and pathological indices has authenticated the diagnostic model (including CST6, TCN2, and KLK5) as the best discrimination of NPSLE from SLE, which has the potential to assist the clinical development of a novel diagnostic system. This evidence concerns the gene TCN2 and systemic lupus erythematosus.